期刊文献+

慢性牙周炎患者血浆β-防御素-2浓度的变化 被引量:1

The Change of Plasma Beta-defensin-2 Concentration in Patients with Chronic Periodontitis
下载PDF
导出
摘要 目的:观察慢性牙周炎患者血浆β-防御素-2浓度的变化,揭示其与慢性牙周炎发病的相关性。方法:收集慢性牙周炎患者和同期牙周健康者各80例。ELISA检测血浆β-防御素-2浓度。统计分析其与慢性牙周炎发病的相关性。结果:经t检验,慢性牙周炎患者血浆β-防御素-2浓度(405.2±133.9)pg/ml显著低于牙周健康者(641.6±128.3)pg/ml(t=6.492,P<0.01)。经Spearman相关分析,慢性牙周炎患者血浆β-防御素-2浓度与牙周探诊深度(r=-0.482,P<0.01)、附着丧失(r=-0.498,P<0.01)和出血指数(r=-0.501,P<0.01)均呈显著负相关。Logistic回归分析显示,血浆β-防御素-2浓度(OR=0.415,95%CI=0.297~0.862,P<0.01)是罹患慢性牙周炎的独立危险因素。ROC曲线分析显示,血浆β-防御素-2浓度预测罹患慢性牙周炎有显著预测价值(曲线下面积=0.843,95%CI=0.774~0.894,P<0.01),且判定血浆β-防御素-2浓度<621.5 pg/ml,对预测罹患慢性牙周炎有81.3%的灵敏度和75.0%的特异度。结论:慢性牙周炎患者血浆β-防御素-2水平降低,血浆β-防御素-2水平降低可能是慢性牙周炎的危险因素。 Objective To observe the change of plasma beta-defensin-2 level was determined in patients with chronic periodonti- tis and its correlation with disease was evaluated. Methods 80 consecutive patients with chronic periodontitis and 80 healthy controls were enrolled into this study. Plasma beta-defensin-2 concentration was measured by ELISA. Its Correlation with disease was analyzed statistically. Results The plasma beta-defensin-2 level (405.2 ±133.9 pg/rnl) in patients was statistically significantly lower than that (641.6 ± 128.3 pg/ml) in healthy controls using t test (t =6. 492, P 〈0.01 ). Spearman correlation coefficient analysis showed that probing depth ( r = - 0.482,P 〈 0.01 ), attachment loss ( r = = 0.498,P 〈 0. 01 ) and bleeding index ( r = - 0.501, P 〈 0. 01 ) were negatively related to plasma beta-defensin-2 level in the patients with chronic periodontitis. On a multivariate logistic regression, plasma beta-defensin-2 level ( OR = 0.415, 95% CI = 0.297±0.862, P 〈 0.01 ) was an independent variable predicting chronic periodontitis. A receiver operating characteristic curve identified that a plasma beta-defensin-2 level 〈 62l. 5 pg,/ml predicted chronic peri- odontitis with 81.3 % sensitivity and 75.0% specificity ( area under curve = 0. 843, 95% CI = 0.774 - 0. 894, P 〈 0.01 ) respectively. Conclusion Deereased beta-defensin-2 was found after chronic periodontitis and low beta-defensin-2 may be independently associated with chronic periodontitis as well as a risk factor.
出处 《放射免疫学杂志》 CAS 2012年第1期49-50,共2页 Journal of Radioimmanology
关键词 Β-防御素-2 慢性牙周炎 危险因素 beta-defensin-2, chronic periodontitis, risk factor
  • 相关文献

参考文献9

  • 1Feres M,Figueiredo LC.Current concepts in the microbial etiology and treatment of chronic periodontitis[J].J Int Acad Periodontol,2009,11(4):234-249.
  • 2Semple CA,Taylor K,Eastwood H,et al.Beta-defensin evolution:selection complexity and clues for residues of functional importance[J].Biochem Soc Trans,2006,34(2):257-262.
  • 3Kuula H,Salo T,Pirila E,et al.Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis[J].Arch Oral Biol,2008,53 (2):175-186.
  • 4Rosen PS.Treatment of plaque-induced gingivitis,chronic periodontitis,and clinical conditions[J].Pediatr Dent,2009,30(7 Suppl):253-262.
  • 5Hujoel PP,Cunha-Ciuz J,Loesche WJ,et al.Personal oral hygiene and chronic periodontitis:a systematic review[J].Periodontol,2005,37(2):29-34.
  • 6Greenstein G,Hart TC.Clinical utility of a genetic susceptibility test for severe chronic periodontitis:a critical evaluation[J].J Am Dent Assoc,2002,133(4):452-459.
  • 7Metz-Boutigue MH,Shooshtarizadeh P,Prevost G,et al.Antimicrobial peptides present in mammalian skin and gut are multifunctional defence molecules[J].Curr Phann Des,2010,16(9):1024-1039.
  • 8Chen H,Xu Z,Peng L,et al.Recent advances in the research and development of human defensins[J].Peptides,2006,27(4):931-940.
  • 9Erichev VP,Gankovskaia LV,Koval'chuk LV,et al.Expression of the antimicrobial peptide beta-defensin-2 in the conjunctival epithelial cells in primary open-angle glaucoma and over tune in the postoperative period[J].Vestn Oftalmol,2010,126(2):19-22.

同被引文献27

  • 1Zeya H L, Spitznagel J K. Antibacterial and enzymic basic pro- teins from leukocyte lysosomes: separation and identification[J]. Science, 1963,142:1085-1087.
  • 2Risso A. Leukocyte antimicrobial peptides: muhifunctional effec- tor molecules of innate immunity[J]. J Leukoc Biol, 2000, 68: 785-792.
  • 3Tomas G. Antimierobial peptides of innate immunity[J]. Nature, 2003,3: 710-720.
  • 4Wu Z B, Hoover D M, Yang D, et 01 . Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of hu- man 13-defensin 3[J]. PNAS, 2003,100: 8880-8885.
  • 5Robert I L, Alex M C, Michael E S. 0-Defensins: cyclic pep- tides with endless potential[J].J Biol Chem, 2012, 287(32): 27014-27019.
  • 6Wanniarachchi Y A, Kaczmarek P, Wan A, et ol. Human defen- sin 5 disulfide array mutants: disulfide bond deletion attenuates antibacterial activity against Staphylococcus aureus [J]. Biochem- istry, 2011,50(37): 8005- 8017.
  • 7Himanshu S , Ramakfishnan N. Antimicrobial activity of human 13- defensin 4 analogs: insights into the role of disulfide linkages in modulating activity [J]. Peptides, 2012,38(2) : 255- 265.
  • 8Maisetta G, Batoni G, Esin S, et 01. Susceptibility of Streptococ- cus mutans and Actinobacillus actinomycetemcomitans to bacte- ricidal activity of human 13-defensin 3 in biological fluids[J]. An- timierob Agents Chemother, 2005, 49(3) : 1245- 1253.
  • 9Seidel A, Ye Y, de Armas L R, et al. Cyc|ic and acyclic defen- sins inhibit human immunodeficiency virus type-1 replication by different mechanisms [J]. PLOS ONE, 2010,5(3): e9737.
  • 10Lehrer R I. Multispecific myeloid defensins[J]. Curr Opin Hema- tol, 2007,14(1): 16-21.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部